Skip to main content
. Author manuscript; available in PMC: 2022 Oct 31.
Published in final edited form as: Am J Gastroenterol. 2020 Mar;115(3):398–405. doi: 10.14309/ajg.0000000000000492

Table 5.

Sensitivity analysis of transferrin for predicting 28- and 90-day mortality

Treatment arm OR 95% CI P
28-day mortality
 Placebo-placebo 0.967 0.952–0.982 <0.0001
 Prednisolone 0.991 0.982–1.000 0.0493
 Pentoxifylline 0.988 0.981–0.996 0.00385
 Prednisolone and pentoxifylline 0.983 0.972–0.994 0.00348
90-day mortality
 Placebo-placebo 0.987 0.979–0.996 0.00249
 Prednisolone 0.995 0.989–1.000 0.0679
 Pentoxifylline 0.990 0.983–0.996 0.00171
 Prednisolone and pentoxifylline 0.990 0.983–0.997 0.00778

The odds ratios with their corresponding 95% confidence intervals for the different treatment arms of the STOPAH trial (2 × 2 factorial design) are presented.